International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Por:
Torres, A, Niederman, MS, Chastre, J, Ewig, S, Fernandez-Vandellos, P, Hanberger, H, Kollef, M, Bassi, GL, Luna, CM, Martin-Loeches, I, Paiva, JA, Read, RC, Rigau, D, Timsit, JF, Welte, T, Wunderink, R
Publicada:
1 sep 2017
Resumen:
The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empiric treatment, response to treatment, new antibiotics or new forms of antibiotic administration and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent.
The European Respiratory Society launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases, were invited to participate and appointed their representatives. The Latin American Thoracic Association was also invited.
A total of 15 experts and two methodologists made up the panel. Three experts from the USA were also invited (Michael S. Niederman, Marin Kollef and Richard Wunderink).
Applying the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology, the panel selected seven PICO (population-intervention-comparison-outcome) questions that generated a series of recommendations for HAP/VAP diagnosis, treatment and prevention.
Filiaciones:
Torres, A:
Univ Barcelona, Hosp Clin Barcelona, Dept Pulmonol, Barcelona, Spain
CIBERES, IDIBAPS, Barcelona, Spain
Niederman, MS:
Weill Cornell Med, Div Pulm & Crit Care Med, New York, NY USA
Chastre, J:
Grp Hosp Pitie Salpetriere, Reanimat Med, Paris, France
Ewig, S:
Evangel Hosp Herne, CAPNETZ Stiftung, Bochum, Germany
Evangel Hosp Herne, Ctr Thorax, Ruhr Area, Dept Resp Med & Infect Dis, Bochum, Germany
Augusta Hosp Bochum, Bochum, Germany
Fernandez-Vandellos, P:
CIBERES, IDIBAPS, Barcelona, Spain
Hanberger, H:
Linkoping Univ, Dept Clin & Expt Med, Fac Med & Hlth Sci, Linkoping, Sweden
Kollef, M:
Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO USA
Bassi, GL:
Univ Barcelona, Hosp Clin Barcelona, Dept Pulmonol, Barcelona, Spain
CIBERES, IDIBAPS, Barcelona, Spain
Luna, CM:
Univ Buenos Aires, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina
Martin-Loeches, I:
Trinity Coll Dublin, St Jamess Hosp, Dept Clin Med, Wellcome Trust HRB Clin Res Facil, Dublin, Ireland
CIBERES, Barcelona, Spain
Paiva, JA:
Univ Porto, Sch Med, Emergency & Intens Care Dept, Ctr Hosp Sao Joao EPE, Oporto, Portugal
Univ Porto, Sch Med, Dept Med, Oporto, Portugal
Read, RC:
Univ Southampton, Acad Unit Clin Expt Sci, Fac Med, Southampton, Hants, England
Univ Southampton, NIHR Southampton Biomed Res Unit, Fac Med, Southampton, Hants, England
Univ Southampton, Inst Life Sci, Southampton, Hants, England
Rigau, D:
Iberoamer Cochrane Ctr, Barcelona, Spain
Timsit, JF:
Paris Diderot Univ, Med & Infect Dis Intens Care Unit, IAME, INSERM,UMR 1137, Paris, France
Hop Xavier Bichat, Paris, France
Welte, T:
Hannover Med Sch, Dept Resp Med, Hannover, Germany
German Ctr Lung Res DZL, Hannover, Germany
Wunderink, R:
Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
Green Submitted, Bronze
|